@article{phelip:hal-01980019,
TITLE = {Modified FOLFIRINOX versus CisGem first-line chemotherapy for locally advanced non resectable or metastatic biliary tract cancer (AMEBICA)-PRODIGE 38: Study protocol for a randomized controlled multicenter phase II/III study},
AUTHOR = {Ph{\'e}lip, Jean-Marc and Edeline, Julien and Blanc, Jean-Fr{\'e}d{\'e}ric and Barbier, Emilie and Michel, Pierre and Bourgeois, Vincent and Neuzillet, Cindy and Malka, David and Manfredi, Sylvain and Desram{\'e},
J{\'e}r{\^o}me},
URL = {https://u-bourgogne.hal.science/hal-01980019},
NOTE = {IF 3.287 (2017)},
JOURNAL = {Digestive and Liver Disease},
PUBLISHER = {Elsevier},
VOLUME = {51},
NUMBER = {2},
PAGES = {318-320},
YEAR = {2019},
MONTH = Feb, DOI = {10.1016/j.dld.2018.11.018},
KEYWORDS = {Modified folfirinox ; Advanced biliary cancer},
HAL_ID = {hal-01980019},
HAL_VERSION = {v1},
}